Literature DB >> 11191655

Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics.

R Gerli1, R Solito, E Weber, M Aglianó.   

Abstract

Anchoring filaments are a characteristic feature of initial lymphatic vessels. They connect the abluminal membrane of endothelial cells to the surrounding elastic fibers. The main molecular component of anchoring filaments is fibrillin. Initial lymphatic vessels of human skin were stained with monoclonal antibodies to fibrillin, integrins alpha 2 beta 1, alpha 3 beta 1 and alpha v beta 3, vinculin, talin, beta-actin and focal adhesion kinase (FAK). A double-labeling immunofluorescence method was used to simultaneously stain fibrillin and alpha 3 beta 1 integrin or FAK. Close contiguities between integrins and anchoring filaments were observed. These results suggest that the anchoring filaments connect the extracellular matrix and the endothelial cell cytoskeleton through the transmembrane integrin and FAK molecule. The results also demonstrate the presence of focal adhesions in the wall of initial lymphatic vessels. These connections possibly enable transmission of chemical and/or mechanical stimuli from the extracellular matrix to the endothelial cells. Here, they are transformed in cytoskeleton rearrangements and intracellular signaling events, some of which may contribute to the initial formation of lymph.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191655

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  29 in total

Review 1.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 3.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 4.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

Review 5.  Lymphangiogenesis and lymphatic vessel remodelling in cancer.

Authors:  Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

6.  Recent developments in morphology of lymphatic vessels and lymph nodes.

Authors:  Osamu Ohtani; Yuko Ohtani
Journal:  Ann Vasc Dis       Date:  2012

Review 7.  Application of microscale culture technologies for studying lymphatic vessel biology.

Authors:  Chia-Wen Chang; Alex J Seibel; Jonathan W Song
Journal:  Microcirculation       Date:  2019-05-02       Impact factor: 2.628

Review 8.  Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases.

Authors:  Daniyal J Jafree; David A Long
Journal:  J Am Soc Nephrol       Date:  2020-04-15       Impact factor: 10.121

Review 9.  Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.

Authors:  Claudio Scavelli; Elisabetta Weber; Margherita Aglianò; Teresa Cirulli; Beatrice Nico; Angelo Vacca; Domenico Ribatti
Journal:  J Anat       Date:  2004-06       Impact factor: 2.610

10.  Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.

Authors:  Ruolin Guo; Quan Zhou; Steven T Proulx; Ronald Wood; Rui-Cheng Ji; Christopher T Ritchlin; Bronislaw Pytowski; Zhenping Zhu; Yong-Jun Wang; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheum       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.